Methods are provided for treating health conditions associated with altered MC4 receptor activity with melanin concentrating hormone receptor antagonists. Such compounds may be used, for example, to treat or prevent obesity and/or overeating, and to reduce body mass index, in patients carrying one or more MC4 receptor mutations.

 
Web www.patentalert.com

< Methods of using thiazolidine derivatives to treat cancer or inflammation

< Aryl carbonyl derivatives as therapeutic agents

> Oxygen-impervious packaging with optional oxygen scavenger, stabilized thyroid hormone compositions and methods for storing thyroid hormone pharmaceutical compositions

> Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
~ 00284